Blog

Bipolar disorder is a mental health condition that affects millions of people worldwide. It is characterized by intense mood swings, ranging from extreme highs, known as manic episodes, to severe lows, known as depressive episodes. While bipolar disorder as a whole is well-known, there are different types of bipolar disorder that individuals can experience. In this article, we will delve into...

The holiday season is often portrayed as a time of joy and celebration. However, for many individuals, it can also be a period of increased stress, anxiety, and even depression. In this article, we will explore the question: do depression rates rise during the holidays? (more…)

Many people struggle with depression, a complex mental health condition that affects hundreds of millions of individuals worldwide. While there are various factors that contribute to the development of depression, one potential cause that has gained significant attention is sleep deprivation. Understanding the relationship between sleep and depression is crucial for effective prevention and...

Ketamine therapy is a novel treatment option for various mental health conditions, and its prevalence has been steadily increasing in recent years. Understanding the science behind ketamine therapy and its therapeutic uses can shed light on its popularity among individuals seeking alternative treatment options for their mental health concerns. This article explores the prevalence, legal...

Anxiety nausea can be a distressing symptom that many individuals experience when they are feeling anxious or stressed. The connection between anxiety and nausea is well-established, and understanding the physiological and psychological mechanisms behind it can help us find ways to alleviate this uncomfortable sensation. (more…)

Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, and Samuel Wilkinson, MD, associate professor of psychiatry, have received $12.6 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) for the study, “Comparative Effectiveness of Racemic Ketamine versus S-Ketamine (Spravato) for Depression.” (more…)

PTSD (post-traumatic stress disorder) is a mental health condition that can develop after experiencing or witnessing a traumatic event. It is a common condition, affecting millions of people worldwide. (more…)

Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year. The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days....

In recent years, ketamine has taken the stage as a powerful alternative to most mood and pain disorder treatments. With great success comes new innovations and derivatives.  Spravato is a prescription drug used to treat: Treatment-resistant depression  Depression involves active suicidal behaviors. Spravato is a nasal spray that can only be used under the strict guidance and instructions of...

40% of males and 20% of females use talk therapy or antidepressants to deal with depression. However, there are five classes of antidepressants, and among those over seventy options, finding the right fit can take months, and each pill has the potential to both not work and come with unwanted side effects. Roughly one-third of all patients that seek treatment for depression find no relief with...